Navigation Links
MADIT-CRT Trial Meets Primary Endpoint
Date:6/23/2009

Landmark trial shows Boston Scientific CRT-Ds slow the progression of heart failure in asymptomatic and mildly symptomatic patients

NATICK, Mass., June 23 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) and the University of Rochester Medical Center today announced that the landmark MADIT-CRT trial has met its primary endpoint. Preliminary results show Boston Scientific cardiac resynchronization therapy defibrillators (CRT-Ds) to be associated with a significant 29 percent reduction (p=0.003) in death or heart failure interventions when compared to traditional implantable cardioverter defibrillators (ICDs). High risk(1), asymptomatic or mildly symptomatic, New York Heart Association (NYHA) Class I and II(2) patients were enrolled in MADIT-CRT. The MADIT-CRT Executive Committee expects to present and publish the trial's full results later this year.

MADIT-CRT, sponsored exclusively by Boston Scientific, demonstrates that early intervention with cardiac resynchronization therapy can slow the progression of heart failure. It is the world's largest randomized NYHA Class I/II CRT-D trial, with more than 1,800 patients enrolled at 110 centers in 14 countries. The trial is being conducted under the leadership of Principal Investigator Arthur J. Moss, M.D., Professor of Medicine at the University of Rochester Medical Center.

"We are very encouraged by these initial positive results, and we are hopeful they will eventually lead to a wider population of heart failure patients being treated with CRT-D therapy," said Fred Colen, President, Boston Scientific CRM. "I would like to congratulate Dr. Moss, the Executive Committee and all the MADIT-CRT investigators on a well designed and well executed clinical trial. Boston Scientific is proud to continue the tradition of supporting a
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. DIA Annual Meeting Attendees Invited to Participate in Electronic Data Capture (EDC) Clinical Trial Survey
2. Amicus Therapeutics Commences Phase 3 Trial Evaluating Amigal(TM) for the Treatment of Fabry Disease
3. Responses After Completion of Therapy Increase Pixantrone Complete Remission (CR)/Unconfirmed Complete Remission (CRu) Rate to 24% and Overall Response Rate (ORR) to 40% Compared to 7% and 14% for Comparator Agents in Phase III EXTEND Trial in 3rd Line Th
4. ProFibrix Initiates Phase II Clinical Trial of its Lead Topical Hemostat Product Fibrocaps(TM)
5. CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Advanced Breast Cancer
6. HEALTHPOINT-Sponsored Venous Leg Ulcer Clinical Trial Enrolls First Subject for Second Phase II Study
7. MacroGenics and Lilly Achieve Targeted Patient Enrollment in PROTEGE, a Global Phase 2/3 Clinical Trial of Teplizumab in Type 1 Diabetes
8. New Legislation Seeks to Boost Participation in Clinical Trials for Rare Diseases
9. VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease
10. Osteotech Completes Enrollment for DuraTech(TM) BioRegeneration Matrix Clinical Trial
11. DOR BioPharma Receives EMEA Agreement on the Design of its Confirmatory Phase 3 Clinical Trial of orBec(R) in GI GVHD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... WAYNE, Pa. , April 1, 2015 /PRNewswire/ ... fully integrated specialty pharmaceutical company focused on developing, ... the pricing of an offering of $60.0 million ... due 2020 (the "notes") in a private placement ... under the Securities Act of 1933, as amended ...
(Date:4/1/2015)... SAN CLEMENTE, Calif. , April 1, 2015 /PRNewswire/ ... residents in the United States ... out amongst their resident colleagues. In its inaugural year, ... and 50 of the top nominations were narrowed to ... voting process that saw over 10,000 votes from colleagues ...
(Date:4/1/2015)... CREEK, Calif. , April 1, 2015  For ... huge difference.  When this is the case, having the ... No one understands this truth better than software solutions ... laboratory management software QATrax.  Recently, the company announced the ... very enthusiastic response from clients. ...
Breaking Medicine Technology:Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 2Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 3Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 4Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 5Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 6Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 7Second Annual $25,000 Honorarium for Exceptional Medical Residents to Accept Nominations in April 2015 2Second Annual $25,000 Honorarium for Exceptional Medical Residents to Accept Nominations in April 2015 3Second Annual $25,000 Honorarium for Exceptional Medical Residents to Accept Nominations in April 2015 4TraxStar Technologies Announces Latest QATrax Test Lab Management Software Now Available 2
(Date:4/1/2015)... 2015 The panel session will look ... providers to build a program that can grow in ... implications further down the line. This topic has taken ... news that OBD-II port dongles aren’t as secure as ... it was reported that Progressive’s Snapshot dongles contained very ...
(Date:4/1/2015)... 2015 Baby Bellies & Beyond Baby ... information on the top products and services to new ... World Records title for "Mommy Moments” - the largest ... annual Baby Bellies & Beyond Expo Orlando on Sunday, ... World Record will commence at 11:00am with actual record ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 BioPlus ... innovative specialty pharmacies, has released a new app to ... guidelines for treating chronic hepatitis C virus (HCV) infection. ... based on information from the American Association for the ... sources. , Numerous new direct-acting oral medications to treat ...
(Date:4/1/2015)... 2015 Dr. Daniel C. Stewart ... April to discuss the benefits of the LANAP® treatment ... from periodontal disease. People who live in Howard County, ... disease can now visit Dr. Stewart, a Maryland dentist, ... With the LANAP® protocol, which is a laser gum ...
(Date:4/1/2015)... OSF Saint Paul Medical Center, the ... was welcomed into the Ministry April 1, 2015, with ... E. Showalter, vicar general of the Catholic Diocese of ... a nearly year-long transition process for the former Mendota ... for the morning ceremony included Sister Judith Ann Duvall, ...
Breaking Medicine News(10 mins):Health News:TU-Automotive: Office of The Privacy Commissioner of Canada To Set Out Privacy Considerations Surrounding UBI Products 2Health News:TU-Automotive: Office of The Privacy Commissioner of Canada To Set Out Privacy Considerations Surrounding UBI Products 3Health News:Baby Bellies & Beyond Attempts To Break Guinness World Records For “Mommy Moments” Largest Gathering Of Pregnant Women April 19 Outside Florida Hotel & Conference Center 2Health News:Baby Bellies & Beyond Attempts To Break Guinness World Records For “Mommy Moments” Largest Gathering Of Pregnant Women April 19 Outside Florida Hotel & Conference Center 3Health News:BioPlus Specialty Pharmacy Releases ‘HCV Treatment Path’ App for Hepatitis C Providers 2Health News:Dr. Daniel C. Stewart Offers Columbia Area Residents an Informational Seminar in April About Less Invasive Gum Disease Treatment Now Available at Smile Savers Dentistry 2Health News:Dr. Daniel C. Stewart Offers Columbia Area Residents an Informational Seminar in April About Less Invasive Gum Disease Treatment Now Available at Smile Savers Dentistry 3Health News:Mendota Community Hospital Now OSF Saint Paul Medical Center 2Health News:Mendota Community Hospital Now OSF Saint Paul Medical Center 3
... Persons treated with Interferon (IFN)to treat chronic hepatitis C ... phase itself//. Retinopathy can develop within two weeks from commencement ... in the journal Investigative Ophthalmology & Visual Science (IOVS)in the ... in Japan gauged the changes in diameter of ...
... more daughters and no sons, may have a greater risk ... team of Israeli researchers compared families of men diagnosed with ... daughters and risk of prostate cancer were related. ... may be a link but the factors responsible for prostate ...
... a little gadget that can be used for 15 minutes ... device, developed by New York based company Helicor, is under ... users to lower their own heartbeat by regulated deep breathing, ... device, also on trial for several other conditions including anxiety ...
... in maintaining weight and a healthy lifestyle. On the same ... and diuretics are superfluous with no proven benefits. , ... alcohol as a temporary measure to freshen up the kidneys ... to pump the body with more antioxidants. Drinking lots of ...
... a premature baby is up for women who have ... eliminate precancerous cells, called LEEP or loop// incision, researchers ... a study involving 5000 women, researchers said that nearly ... incision was avoided. Babies born prematurely are seen battling ...
... girls might want to have another look at that ... to recent studies, teenage girls who read articles on ... prone to resort to drastic weight reducing techniques such ... who don’t. ,The study, published in Pediatrics' January ...
Cached Medicine News:Health News:Gender Of Children May Be Linked To Risk Of Prostate Cancer 2Health News:Drop That Glossy, Girl! 2
... The Instacup Multi-Drug Screen Panel is used for ... human urine. The Instacup Panel consists of a test ... the test card is inserted and the sample sealed ... It is not necessary to remove the test card ...
The Osteomark NTx Point of Care (POC)device allows physicians to monitor their patients response to anti-resorptive drugs as early as 3-6 months from starting treatment. Osteomark NTx shows you and y...
... useful measurement for distinguishing between anemic, ... the preferred diagnostic method for monitoring ... experienced changes in plasma volume including ... also used to measure the effects ...
... enables the fast and exact determination of ... handy photometer and micro-cuvettes, filled with dry ... or arterial blood should be taken with ... so filled cuvette can now be inserted ...
Medicine Products: